Sign in
A randomized controlled trial (RCT) of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus conventional imaging (CI) in staging potentially resectable non-small cell lung cancer (NSCLC)
Journal article   Peer reviewed

A randomized controlled trial (RCT) of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus conventional imaging (CI) in staging potentially resectable non-small cell lung cancer (NSCLC)

D Maziak, G. E Darling, R. I Inculet, K Gulenchyn, A. A Driedger, Y. C Ung, J. D Miller, T Koru-Sengul, W. K Evans and M. N Levine
Journal of clinical oncology, Vol.26(15_suppl), pp.7502-7502
2008-05-20

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.199 Lung Cancer
1.199.425 Lung Cancer
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details